Company / Return on Equity (ROE)
Q32 Bio Inc. Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-841.1%
FY2025
5-year range
-841.1% / -2.8%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Q32 Bio Inc. reports negative total equity of -841.1% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-841.1% in FY2025 with a 5-year CAGR of -800.9%.
Declined from -56.5% to -841.1% over the past 3 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -784.7pp
- 5-Year Change
- -800.9pp
- 10-Year Change
- -
Key checks
Key Insights
- Peak return on equity (roe) was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -841.1% | - |
| FY2024 | - | - |
| FY2023 | -2.8% | +95.0% |
| FY2022 | -56.5% | +14.0% |
| FY2021 | -65.7% | -63.3% |
| FY2020 | -40.2% | -42.0% |
| FY2019 | -28.3% | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026